Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Faivre-Finn

Showing results (41-50 of 84) with videos related to

Pageof 9
Sort By:
Clinical Oncology (Royal College of Radiologists (Great Britain))|July 7, 2021
The Routine Clinical Implementation of Electronic Patient-reported Outcome Measures (ePROMs) at The Christie NHS Foundation TrustC Crockett, F Gomes, C Faivre-Finn, et al.
British Journal of Cancer|July 31, 2008
Phase III randomised trial of doxorubicin-based chemotherapy compared with platinum-based chemotherapy in small-cell lung cancerS Baka, R Califano, R Ferraldeschi, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|March 12, 2011
Survival of patients with non-small cell lung cancer and brain metastasesP Mulvenna, R Barton, P Wilson, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 9, 2020
Recommendation for supportive care in patients receiving concurrent chemotherapy and radiotherapy for lung cancerD De Ruysscher, C Faivre-Finn, K Nackaerts, et al.
Radiography (London, England : 1995)|August 1, 2021
A novel use for routine CBCT imaging during radiotherapy to detect COVID-19A Clough, J Sanders, K Banfill, et al.
Lung Cancer (Amsterdam, Netherlands)|October 22, 2013
Availability of EGFR mutation status at first oncology consultation for advanced non-squamous non-small cell lung cancer patients. A pilot experience from the ChristieM Evans, Y Summers, P Taylor, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 3, 2021
Malignant pleural mesothelioma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up<sup>☆</sup>S Popat, P Baas, C Faivre-Finn, et al.
Clinical and Translational Radiation Oncology|March 22, 2021
Phase I trial of the MEK inhibitor selumetinib in combination with thoracic radiotherapy in non-small cell lung cancerK Haslett, P Koh, A Hudson, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|April 17, 2024
An Overview of Real-World Data Infrastructure for Cancer ResearchG Price, N Peek, I Eleftheriou, et al.
Lung Cancer (Amsterdam, Netherlands)|May 28, 2020
Cardiovascular mortality and morbidity following radical radiotherapy for lung cancer: Is cardiovascular death under-reported?F Sun, K Franks, L Murray, et al.
Pageof 9

Showing results (41-50 of 84) with videos related to

Sort By:
Pageof 9
Clinical Oncology (Royal College of Radiologists (Great Britain))|July 7, 2021
The Routine Clinical Implementation of Electronic Patient-reported Outcome Measures (ePROMs) at The Christie NHS Foundation TrustC Crockett, F Gomes, C Faivre-Finn, et al.
British Journal of Cancer|July 31, 2008
Phase III randomised trial of doxorubicin-based chemotherapy compared with platinum-based chemotherapy in small-cell lung cancerS Baka, R Califano, R Ferraldeschi, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|March 12, 2011
Survival of patients with non-small cell lung cancer and brain metastasesP Mulvenna, R Barton, P Wilson, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 9, 2020
Recommendation for supportive care in patients receiving concurrent chemotherapy and radiotherapy for lung cancerD De Ruysscher, C Faivre-Finn, K Nackaerts, et al.
Radiography (London, England : 1995)|August 1, 2021
A novel use for routine CBCT imaging during radiotherapy to detect COVID-19A Clough, J Sanders, K Banfill, et al.
Lung Cancer (Amsterdam, Netherlands)|October 22, 2013
Availability of EGFR mutation status at first oncology consultation for advanced non-squamous non-small cell lung cancer patients. A pilot experience from the ChristieM Evans, Y Summers, P Taylor, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 3, 2021
Malignant pleural mesothelioma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up<sup>☆</sup>S Popat, P Baas, C Faivre-Finn, et al.
Clinical and Translational Radiation Oncology|March 22, 2021
Phase I trial of the MEK inhibitor selumetinib in combination with thoracic radiotherapy in non-small cell lung cancerK Haslett, P Koh, A Hudson, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|April 17, 2024
An Overview of Real-World Data Infrastructure for Cancer ResearchG Price, N Peek, I Eleftheriou, et al.
Lung Cancer (Amsterdam, Netherlands)|May 28, 2020
Cardiovascular mortality and morbidity following radical radiotherapy for lung cancer: Is cardiovascular death under-reported?F Sun, K Franks, L Murray, et al.
Pageof 9